NCT06697028View on ClinicalTrials.gov

Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever

CompletedOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

December 25, 2024

Primary Completion Date

January 11, 2025

Study Completion Date

May 11, 2025

Conditions
Juvenile Idiopathic ArthritisFamilial Mediterranean FeverHealty Controls
Interventions
OTHER

Usability and Comparison

PACER will be used to assess cardiorespiratory fitness in individuals with rheumatic diseases. The results will be compared with those of healthy individuals, and the relationship between body composition and VO2 max will be examined.

Trial Locations (1)

Unknown

Istanbul University-Cerrahpasa, Istanbul

All Listed Sponsors
lead

Istanbul University - Cerrahpasa

OTHER

NCT06697028 - Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever | Biotech Hunter | Biotech Hunter